tiprankstipranks
Comera Life Sciences Holdings Inc. (CMRA)
:CMRA
US Market

Comera Life Sciences Holdings (CMRA) Income Statement

Compare
25 Followers

Comera Life Sciences Holdings Income Statement

Last quarter (Q3 2023), Comera Life Sciences Holdings's total revenue was $136.31K, a decrease of -41.98% from the same quarter last year. In Q3, Comera Life Sciences Holdings's net income was $-2.15M. See Comera Life Sciences Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20
Total Revenue
$ 633.10K$ 319.83K$ 442.92K
Gross Profit
$ 422.71K$ 158.82K$ 338.51K
Operating Expenses
$ 12.39M$ 5.69M$ 2.47M
Depreciation and Amortization
$ 93.95K$ 88.82K$ 89.75K
EBITDA
$ -17.89M$ -5.36M$ -2.04M
Operating Income
$ -11.97M$ -5.54M$ -2.13M
Other Income/Expenses
$ -6.03M$ 83.85K$ 2.03K
Pretax Income
$ -18.00M$ -5.45M$ -2.13M
Net Income
$ -18.00M$ -5.29M$ -2.13M
Per Share Metrics
$ ―$ ―$ ―
Basic EPS
$ -1.76$ -0.28$ -0.11
Diluted EPS
$ -1.76$ -0.28$ -0.11
Weighted Average Shares Outstanding
10.45M 19.09M 19.09M
Weighted Average Shares Outstanding (Diluted)
10.45M 19.09M 19.09M
Currency in USD

Comera Life Sciences Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis